The use of biochemical markers of bone turnover in osteoporosis. Committee of Scientific Advisors of the International Osteoporosis Foundation.
Delmas
P D
PD
Inserm Research Unit 403 and Claude Bernard University of Lyon, France. delmas@lyon151inserm.fr
Eastell
R
R
Garnero
P
P
Seibel
M J
MJ
Stepan
J
J
D015415:Biomarkers / Q000097:blood / Q000652:urine; D015519:Bone Density / Q000502:physiology; D001861:Bone Regeneration / Q000502:physiology; D016723:Bone Remodeling / Q000502:physiology*; D001862:Bone Resorption / Q000378:metabolism; D004164:Diphosphonates / Q000627:therapeutic use; D004967:Estrogens / Q000627:therapeutic use; D005260:Female; D005598:Fractures, Spontaneous / Q000175:diagnosis / Q000209:etiology / Q000517:prevention & control; D006801:Humans; D010024:Osteoporosis / Q000175:diagnosis* / Q000188:drug therapy / Q000503:physiopathology; D015663:Osteoporosis, Postmenopausal / Q000175:diagnosis / Q000188:drug therapy / Q000503:physiopathology; D010507:Periodicity; D011379:Prognosis; D020849:Raloxifene Hydrochloride / Q000627:therapeutic use; D018570:Risk Assessment; D009626:Terminology as Topic
D015415:Biomarkers; D004164:Diphosphonates; D004967:Estrogens; D020849:Raloxifene Hydrochloride